Eruptive Sebaceous Hyperplasia: A Case Report and Review of the Literature
Open Access
- 31 August 2023
- journal article
- review article
- Published by HCA Healthcare in HCA Healthcare Journal of Medicine
- Vol. 4 (4) , 9-319
Abstract
Introduction Eruptive sebaceous hyperplasia (ESH) is a benign process characterized by the acute onset and rapid proliferation of sebaceous glands, typically on the face. Although historically attributed to cyclosporine therapy, the preponderance of reports over the past 2 decades suggests a more complex etiology. There is increasing thought a combination of multiple medications as well as a genetic component contribute to ESH’s clinical presentation. Despite these theories, the exact cause of ESH in immunosuppressive therapy is poorly understood. Case Presentation To our knowledge, we report the third case of ESH arising in multimodality immunosuppressive therapy, consisting of tacrolimus, mycophenolate mofetil, and prednisone, affecting a renal transplant patient. Our patient began cyclosporine monotherapy at an early age but did not see eruption of lesions until years later after following a multimodal therapy. Conclusion We discuss the association of ESH with other medical conditions and treatments. We hope this case sheds light on a possible complication of multimodal immunosuppressive therapy in renal transplant patients. This will allow patients and providers to be better informed of the pros and cons of different treatment options for immunosuppressive therapy in renal transplant patients.Keywords
This publication has 10 references indexed in Scilit:
- Eruptive Sebaceous Hyperplasia: A Rare Consequence of Systemic Corticosteroids2018
- Eruptive sebaceous hyperplasia as a side effect of oral tacrolimus in a renal transplant recipientDermatology Online Journal, 2017
- Multiple Eruptive Sebaceous Hyperplasia Secondary to Cyclosporin in a Patient with Bone Marrow TransplantationDermatopathology, 2016
- A Case of Cyclosporine-Induced Sebaceous Hyperplasia in a Renal Transplant Patient Successfully Treated with IsotretinoinAnnals of Dermatology, 2016
- Successful treatment of cyclosporine-induced sebaceous hyperplasia with oral isotretinoin in two renal transplant recipientsAustralasian Journal of Dermatology, 2011
- Coexistence of Basal Cell Carcinomas and Multiple Sebaceous Gland Hyperplasias in a Cyclosporine (Ciclosporin)-Treated Renal Transplant RecipientAmerican Journal of Clinical Dermatology, 2010
- Eruptive sebaceous hyperplasia in association with chronic renal failureClinical and Experimental Dermatology, 2009
- Topical Photodynamic Therapy With Methyl Aminolevulinate to Treat Sebaceous Hyperplasia in an Organ Transplant RecipientArchives of Dermatology, 2006
- Ciclosporin A-induced sebaceous gland hyperplasiaBritish Journal of Dermatology, 2003
- Eruptive lesions in a patient with bone marrow transplantationInternational Journal of Dermatology, 2001